News
Dr. Reddy's Laboratories Ltd. closed 8.46% below its 52-week high of 1,420.20 rupees, which the company reached on August 21st.
13h
Capital Market on MSNDr Reddys Laboratories Ltd soars 0.02%, rises for fifth straight sessionDr Reddys Laboratories Ltd gained for a fifth straight session today. The stock is quoting at Rs 1287.7, up 0.02% on the day ...
India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...
Hyderabad: Dr. Reddy’s Laboratories Ltd has announced an investment of Rs 565.4 crore in its step-down wholly owned ...
6don MSN
Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...
Indian headline indices declined for the third consecutive session due to selling pressure in IT, banks, and realty stocks.
Indian generic drugs maker Dr Reddy's Laboratories posted a narrow miss of quarterly profit expectations on Wednesday, as it ...
Dr. Reddy's Laboratories Ltd. closed 9.41% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...
Dr Reddy's Laboratories share price gained almost 3% in the morning trades on Thursday post Q1 results that were declared ...
Hyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an ...
DRL posted a 2 per cent YoY increase in PAT to Rs 1,417.8 crore for Q1 FY26, compared with Rs 1,392 crore in the year-ago ...
Motilal Oswal recommended Neutral rating on Dr Reddys Labs with a target price of Rs 1190 in its research report dated July ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results